All In Biotech

Drug Trial Radar · NCT06145893

A Study of Efficacy and Safety of Hemay005 Tablets in Patients With Behçet's Disease

A Phase III Clinical Study of Efficacy and Safety of Hemay005 Tablets in Patients With Behçet's Disease

Last checked: Nov 19, 2026Latest source record: Apr 8, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 162 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

162

Planned (sponsor's estimate)

Start

Nov 13, 2023

Primary completion

May 30, 2026

Study completion Jun 30, 2026

Sponsor

Sponsor type
Industry
First posted
Nov 24, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a phase 3, multi-center, randomized, placebo-controlled, double-blind, parallel-group study with an equal randomization among the Hemay005 high dose, lower dose and placebo treatment groups. After subject randomization, each subject will enter an core-treatment Phase for 12 weeks following an extended-treatment phase for another 40 weeks and a follow up phase for 4weeks.

Conditions

  • Behçet's Disease

Interventions

  • Hemay005Drug

    Hemay005 tables 60mg bid p.o;

  • Hemay005Drug

    Hemay005 tables 45mg bid p.o;

  • PlaceboDrug

    placebo to Hemay005 tables bid p.o

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Efficacy assessed by oral ulcersTime frame: week 12

Locations

22 sites in 1 country. Site status is shown where the registry gives one.

  • The first affiliated hospital of Wenzhou Medical university

    Wenzhou, China · Recruiting

  • Beijing Friendship hospital capital medical hospital

    Beijing, Beijing Municipality, China · Recruiting

  • Peking university first hospital

    Beijing, Beijing Municipality, China · Recruiting

  • Peking University People's Hospital

    Beijing, Beijing Municipality, China · Recruiting

  • Peking university third hospital

    Beijing, Beijing Municipality, China · Recruiting

  • Xuanwu hospital capital medical university

    Beijing, Beijing Municipality, China · Recruiting

  • The first affiliated hospital of Xiamen University

    Xiamen, Fujian, China · Recruiting

  • Guangdong second provincial central hospital

    Guangzhou, Guangdong, China · Recruiting

  • Sun Yat-Sen memorial hospital

    Guangzhou, Guangdong, China · Recruiting

  • The third affiliated hospital sun yat-sen university

    Guangzhou, Guangdong, China · Recruiting

  • The university of Hong Kong-Shenzhen Hospital

    Shenzhen, Guangdong, China · Recruiting

  • Affiliated hospital of Guilin Medical university

    Guilin, Guangxi, China · Recruiting

  • The second hospital of Hebei medical university

    Shijiazhuang, Hebei, China · Not yet recruiting

  • Xinxiang Central hospital

    Xinxiang, Henan, China · Recruiting

  • The first affiliated hospital of Nanchang university

    Nanchang, Jiangsu, China · Recruiting

  • The first affiliated hospital of Soochow university

    Suzhou, Jiangsu, China · Recruiting

  • The affiliated hospital of Xuzhou medical university

    Xuzhou, Jiangsu, China · Recruiting

  • Jilin Province People's hospital

    Changchun, Jilin, China · Recruiting

  • Linyi People's Hospital

    Linyi, Shandong, China · Not yet recruiting

  • Tongji hospital of Tongji university

    Shanghai, Shanghai Municipality, China · Recruiting

  • Second hospital of shanxi medical university

    Taiyuan, Shanxi, China · Not yet recruiting

  • The first affiliated hospital, Zhejiang University school of medicine

    Hangzhou, Zhejiang, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.